Berenice Y. Gitomer

1.8k total citations
53 papers, 1.1k citations indexed

About

Berenice Y. Gitomer is a scholar working on Genetics, Nephrology and Molecular Biology. According to data from OpenAlex, Berenice Y. Gitomer has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Genetics, 24 papers in Nephrology and 19 papers in Molecular Biology. Recurrent topics in Berenice Y. Gitomer's work include Genetic and Kidney Cyst Diseases (50 papers), Renal and related cancers (18 papers) and Renal Diseases and Glomerulopathies (15 papers). Berenice Y. Gitomer is often cited by papers focused on Genetic and Kidney Cyst Diseases (50 papers), Renal and related cancers (18 papers) and Renal Diseases and Glomerulopathies (15 papers). Berenice Y. Gitomer collaborates with scholars based in United States, France and Germany. Berenice Y. Gitomer's co-authors include Michel Chonchol, Robert W. Schrier, Wei Wang, Kristen L. Nowak, Melissa A. Cadnapaphornchai, Godela Brosnahan, Jelena Klawitter, Diana George, Vicente E. Torres and Kim McFann and has published in prestigious journals such as Scientific Reports, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Berenice Y. Gitomer

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berenice Y. Gitomer United States 19 905 559 322 270 187 53 1.1k
Wendy E. Boertien Netherlands 16 482 0.5× 405 0.7× 408 1.3× 183 0.7× 107 0.6× 19 980
William G. van’t Hoff United Kingdom 18 474 0.5× 732 1.3× 251 0.8× 309 1.1× 347 1.9× 31 1.3k
Daigoro Hirohama Japan 16 102 0.1× 298 0.5× 238 0.7× 52 0.2× 66 0.4× 34 816
Mansi Dalal United States 9 146 0.2× 94 0.2× 328 1.0× 89 0.3× 21 0.1× 16 647
Hsien‐Hsien Lei United States 5 133 0.1× 148 0.3× 93 0.3× 116 0.4× 32 0.2× 6 417
F.C. Logue United Kingdom 17 76 0.1× 198 0.4× 208 0.6× 125 0.5× 51 0.3× 37 748
Hideo Koike Japan 10 93 0.1× 421 0.8× 27 0.1× 84 0.3× 124 0.7× 26 685
Jens Iversen Denmark 9 202 0.2× 69 0.1× 121 0.4× 65 0.2× 30 0.2× 9 476
A Greenwalt United States 6 101 0.1× 156 0.3× 401 1.2× 119 0.4× 56 0.3× 8 671
A. P. Provoost Netherlands 18 80 0.1× 138 0.2× 328 1.0× 69 0.3× 202 1.1× 32 777

Countries citing papers authored by Berenice Y. Gitomer

Since Specialization
Citations

This map shows the geographic impact of Berenice Y. Gitomer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berenice Y. Gitomer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berenice Y. Gitomer more than expected).

Fields of papers citing papers by Berenice Y. Gitomer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berenice Y. Gitomer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berenice Y. Gitomer. The network helps show where Berenice Y. Gitomer may publish in the future.

Co-authorship network of co-authors of Berenice Y. Gitomer

This figure shows the co-authorship network connecting the top 25 collaborators of Berenice Y. Gitomer. A scholar is included among the top collaborators of Berenice Y. Gitomer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berenice Y. Gitomer. Berenice Y. Gitomer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gitomer, Berenice Y., Wei Wang, Diana George, et al.. (2025). A randomized controlled trial evaluated the effect of pravastatin on kidney disease outcomes in adult patients with early-stage autosomal dominant polycystic kidney disease. Kidney International. 109(2). 390–397. 2 indexed citations
2.
Gitomer, Berenice Y., Michel Chonchol, Xiaolei Zhou, et al.. (2024). Kidney Stone Disease and Progression Risk in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of OVERTURE. Kidney360. 5(9). 1364–1366.
3.
Wang, Wei, et al.. (2023). Imaging Biomarkers in Young Patients With ADPKD. Kidney International Reports. 8(10). 2153–2155. 1 indexed citations
4.
Kleczko, Emily K., Michael Berger, Seth B. Furgeson, et al.. (2023). Immune checkpoint activity regulates polycystic kidney disease progression. JCI Insight. 8(12). 9 indexed citations
5.
Perrone, Ronald D., Dorothee Oberdhan, John Ouyang, et al.. (2023). OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD. Kidney International Reports. 8(5). 989–1001. 17 indexed citations
6.
Klawitter, Jost, Cristina Sempio, Katharina Hopp, et al.. (2022). Endocannabinoid System in Polycystic Kidney Disease. American Journal of Nephrology. 53(4). 264–272. 5 indexed citations
7.
Hopp, Katharina, Emily K. Kleczko, Berenice Y. Gitomer, et al.. (2022). Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease. American Journal of Physiology-Renal Physiology. 322(3). F258–F267. 21 indexed citations
8.
Kleczko, Emily K., Nidhi Dwivedi, Berenice Y. Gitomer, et al.. (2022). The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression. JCI Insight. 8(1). 13 indexed citations
9.
Klawitter, Jost, Katharina Hopp, Michel Chonchol, et al.. (2022). Kynurenines in polycystic kidney disease. Journal of Nephrology. 36(1). 83–91. 11 indexed citations
10.
You, Zhiying, Berenice Y. Gitomer, Godela Brosnahan, et al.. (2021). PKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies. Kidney International Reports. 7(1). 117–120. 5 indexed citations
11.
Brosnahan, Godela, Wei Wang, Berenice Y. Gitomer, et al.. (2021). Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study. American Journal of Kidney Diseases. 79(4). 518–526. 34 indexed citations
12.
Griffin, Benjamin R., Zhiying You, Lama Noureddine, et al.. (2020). KIM-1 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease: HALT-PKD Results. American Journal of Nephrology. 51(6). 473–479. 13 indexed citations
13.
Hopp, Katharina, Émilie Cornec-Le Gall, Sarah R. Senum, et al.. (2019). Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease. Kidney International. 97(2). 370–382. 49 indexed citations
14.
Perrone, Ronald D., Samer Mouksassi, Klaus Romero, et al.. (2017). Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease. Kidney International Reports. 2(3). 442–450. 91 indexed citations
15.
Perrone, Ronald D., Samer Mouksassi, Klaus Romero, et al.. (2017). A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease. Kidney International Reports. 2(3). 451–460. 18 indexed citations
16.
Nowak, Kristen L., Melissa A. Cadnapaphornchai, Michel B. Chonchol, Robert W. Schrier, & Berenice Y. Gitomer. (2016). Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease. American Journal of Nephrology. 44(3). 171–178. 26 indexed citations
17.
Klawitter, Jelena, Kim McFann, Wei Wang, et al.. (2015). Pravastatin Therapy and Biomarker Changes in Children and Young Adults with Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology. 10(9). 1534–1541. 23 indexed citations
18.
Cadnapaphornchai, Melissa A., Diana George, Kim McFann, et al.. (2014). Effect of Pravastatin on Total Kidney Volume, Left Ventricular Mass Index, and Microalbuminuria in Pediatric Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology. 9(5). 889–896. 120 indexed citations
19.
Klawitter, Jelena, Iram Zafar, Jost Klawitter, et al.. (2013). Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease. BMC Nephrology. 14(1). 165–165. 17 indexed citations
20.
Amura, Claudia R., Kelley S. Brodsky, Berenice Y. Gitomer, et al.. (2008). CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation. American Journal of Physiology-Cell Physiology. 294(3). C786–C796. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy E. Boertien Breakdown of academic impact, for papers by William G. van’t Hoff Breakdown of academic impact, for papers by Daigoro Hirohama Breakdown of academic impact, for papers by Mansi Dalal Breakdown of academic impact, for papers by Hsien‐Hsien Lei Breakdown of academic impact, for papers by F.C. Logue Breakdown of academic impact, for papers by Hideo Koike Breakdown of academic impact, for papers by Jens Iversen Breakdown of academic impact, for papers by A Greenwalt Breakdown of academic impact, for papers by A. P. Provoost
Rankless by CCL
2026